Is ABBV up or down today?
ABBV is up 0.16% today, last at 263.62. This stock moved +0.16% versus the prior close.
ABBV · AbbVie
ABBV (AbbVie) is trading at 263.62, up 0.16% on the session. Price action and momentum indicators lean constructive.
Over the past 7 days, 29 headlines skew mixed. Earnings and Macro/Market themes dominated coverage.
Social buzz is mixed — no strong crowd signal.
Analyst firms are mostly reiterating — no strong directional shift lately.
ABBV is up 0.16% today, last at 263.62. This stock moved +0.16% versus the prior close.
Over the past 7 days, 29 headlines skew mixed. Earnings and Macro/Market themes dominated coverage. Dominant story: AbbVie (ABBV) Heads Into Results With Skyrizi and Rinvoq Carrying More of the Growth Burden - news.alphastreet.com (3 sources, neutral) RSI is 67 — leaning bullish Price above 50-day average — short-term uptrend Social (demo): 42% of recent mentions lean bullish — mixed social mood.
Loaded: Jan 2026 – Jul 2026 (124 days) · Drag or scroll left for earlier dates
Analyst firms are mostly reiterating — no strong directional shift lately.
Google Trends data is temporarily unavailable — common on cloud hosts. Search interest is optional context only.
Based on 10,656 mentions over 30d
AbbVie (ABBV) Heads Into Results With Skyrizi and Rinvoq Carrying More of the Growth Burden - news.alphastreet.com
The Real Price of AbbVie Stock Is Cheaper Than You Think - Trefis
The Real Price of AbbVie Stock Is Cheaper Than You Think
AbbVie Has Raised Its Dividend for 53 Straight Years and Still Looks Attractively Valued. Is This Dividend King the Smartest Buy in Healthcare Right Now?
ABBV Looks 23.5% Overvalued on GF Value™ as Dividend Sustainabil - GuruFocus
Will AbbVie Q2 Global Skyrizi net revenues be above $20B?
Will AbbVie Q2 Global Skyrizi net revenues be above $19B?